Juanita Brooks of Fish & Richardson, left, and William Jay of Goodwin Procter
Time is of the essence as GlaxoSmithKline and Teva dispute whether a generic version of cardiovascular drug Coreg infringed GSK's method of using it to treat congestive heart failure.
September 05, 2019 at 05:17 PM
1 minute read
Juanita Brooks was hunting for a $235 million citation.
Time was winding down on an hour-long argument in which the Fish & Richardson partner was trying to revive a $235 million jury award that Brooks had won for GlaxoSmithKline LLC, but that Chief U.S. District Judge Leonard Stark of the District of Delaware had thrown out on posttrial motions.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
